Global Bone Graft Substitutes Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Allograft BGS, Synthetic BGS, and 1 more

In 2022, The Global Bone Graft Substitutes Market was valued at approximately $2 billion. This is anticipated to increase at a CAGR of 3.9% to reach approximately $2.7 billion within the forecast period.

The complete report suite on the global market for bone graft substitutes (BGS) includes coverage on allograft BGS, demineralized bone matrix allograft BGS and synthetic BGS. The market is further analyzed by unit type. Specifically, they are divided by nine types of indication: cervical, thoracolumbar spine, non-union trauma, fresh facture trauma, hip bone, knee bone, foot bone, craniomaxillofacial and oncology.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Sports Medicine Procedure Volumes
• Market Forecasts Until 2029, and Historical Data to 2022
• Market Drivers & Limiters for each Sports Medicine market segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

PROCEDURE NUMBERS

Efficient use of bone graft substitute has been a limiter for the bone graft substitute market because of cost control on the part of hospitals. The volume of bone graft substitute used per procedure has been diminishing incrementally.

GLOBAL ORTHOPEDIC BONE GRAFT SUBSTITUTES MARKET INSIGHTS

The total market for bone graft substitutes, which included allografts, demineralized bone matrices (DBMs) and synthetic grafts, grew in 2022 compared to the previous year. Market growth has been supported by the strong adoption of the BMP growth factor market, which is represented by Medtronic’s INFUSE® product.

GLOBAL ORTHOPEDIC BONE GRAFT SUBSTITUTES MARKET SHARE INSIGHTS

The global orthopedic bone graft substitutes market is lead by three main companies: Medtronic, Stryker, and DePuy Synthes.

In 2022, Medtronic was the frontrunner in the bone graft substitutes market due to a leading share in the demineralized bone graft market, as well as the synthetic bone graft market. Medtronic’s Grafton® is the first fiber-based demineralized bone matrix allograft BGS and remains one of the most popular products in this market.

GLOBAL ORTHOPEDIC BONE GRAFT SUBSTITUTES MARKET SEGMENTATION SUMMARY

• Allograft Bone Graft Substitute Market
• Demineralized Bone Matrix Allograft Market
• Synthetic Bone Graft Substitute Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2022

Forecast: 2023-2029

Historical Data: 2019-2022

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.